Entities / Company
Zynex.
American medical device manufacturer
- Reports this week
- 0
- Active events
- 0
- Connections
- 16
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Thomas Sandgaard was appointed President and CEO of Zynex, while Tricare continued its payment suspension.Some support2 reports
-
Zynex, founded by Thomas Sandgaard, is addressing the sepsis burden cited by the CDC, with Sandgaard and Donald Gregg holding key roles.Speculative1 report
-
Steven Dyson was appointed Chief Executive Officer of Zynex on June 30, 2025, the company was founded by Thomas Sandgaard in 1996.Speculative1 report
-
Zynex submitted its NiCO laser pulse oximeter to the FDA for review.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Zynex this week
News at the entities that move Zynex most-
FDA StructuralHelus Pharma is seeking review from the FDA for its drug candidate HLP003, led by company executive Eric So.Moves Zynex
-
Tricare OperationalHHS granted CMS power to bar providers from Medicare and Tricare, and CMS ran an AI fraud test pilot in Indiana.Moves Zynex
-
MarketBeat Mentioned togetherMarketBeat reports analyst recommendations for finance companies First Bancorp and Bankwell Financial Group.Moves Zynex
-
Nasdaq Shared contextThe Leverage Shares 2x Long HOOD Daily ETF began trading on the Nasdaq exchange on October 1, 2026.Moves Zynex
Connections
The 6 strongest of 16, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Tricare Operational
Zynex and Tricare maintain an active operational relationship involving claims processing and payments, with allegations of revenue inflation.
-
Thomas Sandgaard Structural
Thomas Sandgaard is the founder and CEO of Zynex.
-
FDA Structural
Zynex relies on the FDA for regulatory review and approval of its medical devices.
-
Avita Medical Operational
Both companies function as small-cap competitors within the specialized healthcare market.
-
MarketBeat Mentioned together
MarketBeat provides analyst ratings and market coverage for Zynex.
-
Nasdaq Shared context
Zynex is listed and trades on the Nasdaq stock exchange.
History
Events by the month they beganSeptember 2026
1 eventJuly 2026
1 eventJune 2026
4 events- Thomas Sandgaard was appointed President and CEO of Zynex, while Tricare continued its payment suspension.
- Zynex, founded by Thomas Sandgaard, is addressing the sepsis burden cited by the CDC, with Sandgaard and Donald Gregg holding key roles.
- Steven Dyson was appointed Chief Executive Officer of Zynex on June 30, 2025, the company was founded by Thomas Sandgaard in 1996.
- Zynex submitted its NiCO laser pulse oximeter to the FDA for review.